These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 36221037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray.
    Yang PS, Peng HY, Lin TB, Hsieh MC, Lai CY, Lee AS, Wang HH, Ho YC.
    Neuropharmacology; 2020 Nov 01; 178():108269. PubMed ID: 32791085
    [Abstract] [Full Text] [Related]

  • 3. Periaqueductal gray is required for controlling chronic stress-induced depression-like behavior.
    Peng WH, Kan HW, Ho YC.
    Biochem Biophys Res Commun; 2022 Feb 19; 593():28-34. PubMed ID: 35051779
    [Abstract] [Full Text] [Related]

  • 4. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
    Ghosal S, Bang E, Yue W, Hare BD, Lepack AE, Girgenti MJ, Duman RS.
    Biol Psychiatry; 2018 Jan 01; 83(1):29-37. PubMed ID: 28751069
    [Abstract] [Full Text] [Related]

  • 5. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray.
    Chou D, Peng HY, Lin TB, Lai CY, Hsieh MC, Wen YC, Lee AS, Wang HH, Yang PS, Chen GD, Ho YC.
    Neuropharmacology; 2018 Sep 01; 139():1-12. PubMed ID: 29953886
    [Abstract] [Full Text] [Related]

  • 6. Brain-derived neurotrophic factor in the ventrolateral periaqueductal gray contributes to (2R,6R)-hydroxynorketamine-mediated actions.
    Chou D.
    Neuropharmacology; 2020 Jun 15; 170():108068. PubMed ID: 32222405
    [Abstract] [Full Text] [Related]

  • 7. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
    Voleti B, Navarria A, Liu RJ, Banasr M, Li N, Terwilliger R, Sanacora G, Eid T, Aghajanian G, Duman RS.
    Biol Psychiatry; 2013 Nov 15; 74(10):742-9. PubMed ID: 23751205
    [Abstract] [Full Text] [Related]

  • 8. The Requirement of L-Type Voltage-Dependent Calcium Channel (L-VDCC) in the Rapid-Acting Antidepressant-Like Effects of Scopolamine in Mice.
    Yu H, Li M, Shen X, Lv D, Sun X, Wang J, Gu X, Hu J, Wang C.
    Int J Neuropsychopharmacol; 2018 Feb 01; 21(2):175-186. PubMed ID: 29020410
    [Abstract] [Full Text] [Related]

  • 9. Engeletin alleviates depression-like phenotype by increasing synaptic plasticity via the BDNF-TrkB-mTORC1 signalling pathway.
    Xu Y, Zhang J, Yu L, Zhang W, Zhang Y, Shi Y, Zhang S, Li C, Tian J.
    J Cell Mol Med; 2023 Dec 01; 27(23):3928-3938. PubMed ID: 37799103
    [Abstract] [Full Text] [Related]

  • 10. Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation.
    Babii Y, Pałucha-Poniewiera A, Rafało-Ulińska A, Brański P, Pilc A.
    Pharmacol Rep; 2024 Oct 01; 76(5):1001-1011. PubMed ID: 39042346
    [Abstract] [Full Text] [Related]

  • 11. BTRX-246040 Acts Through the Ventrolateral Periaqueductal Gray to Exert Antidepressant-Relevant Actions in Mice.
    Li Z, Xu Y, Li R, Sheng Z, Chen X, Liu X, Lee CS, Peng HY, Lin TB, Hsieh MC, Lai CY, Wu HF, Chou D.
    Int J Neuropsychopharmacol; 2023 Jul 31; 26(7):483-495. PubMed ID: 37279653
    [Abstract] [Full Text] [Related]

  • 12. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H, Fukumoto K, Iijima M, Chaki S.
    Behav Brain Res; 2013 Feb 01; 238():48-52. PubMed ID: 23098797
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling.
    Rosa PB, Bettio LEB, Neis VB, Moretti M, Kaufmann FN, Tavares MK, Werle I, Dalsenter Y, Platt N, Rosado AF, Fraga DB, Heinrich IA, Freitas AE, Leal RB, Rodrigues ALS.
    Purinergic Signal; 2021 Jun 01; 17(2):285-301. PubMed ID: 33712981
    [Abstract] [Full Text] [Related]

  • 14. BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model.
    Ju L, Yang J, Zhu T, Liu P, Yang J.
    BMC Psychiatry; 2022 Mar 15; 22(1):182. PubMed ID: 35291971
    [Abstract] [Full Text] [Related]

  • 15. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
    Deyama S, Aoki S, Sugie R, Fukuda H, Shuto S, Minami M, Kaneda K.
    Neurotherapeutics; 2023 Mar 15; 20(2):484-501. PubMed ID: 36622634
    [Abstract] [Full Text] [Related]

  • 16. Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice.
    Zhang SS, Tian YH, Jin SJ, Wang WC, Zhao JX, Si XM, Zhang L, Xu H, Jin JY.
    Psychopharmacology (Berl); 2019 Nov 15; 236(11):3301-3315. PubMed ID: 31197433
    [Abstract] [Full Text] [Related]

  • 17. Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression.
    Ho YC, Lin TB, Hsieh MC, Lai CY, Chou D, Chau YP, Chen GD, Peng HY.
    Neuropsychopharmacology; 2018 Jan 15; 43(2):302-312. PubMed ID: 28853438
    [Abstract] [Full Text] [Related]

  • 18. A Selective M1 and M3 Receptor Antagonist, Penehyclidine Hydrochloride, Exerts Antidepressant-Like Effect in Mice.
    Sun X, Sun C, Zhai L, Dong W.
    Neurochem Res; 2019 Dec 15; 44(12):2723-2732. PubMed ID: 31606838
    [Abstract] [Full Text] [Related]

  • 19. Licorisoflavan A Exerts Antidepressant-Like Effect in Mice: Involvement of BDNF-TrkB Pathway and AMPA Receptors.
    Xiao D, Liu L, Li Y, Ruan J, Wang H.
    Neurochem Res; 2019 Sep 15; 44(9):2044-2056. PubMed ID: 31278631
    [Abstract] [Full Text] [Related]

  • 20. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.
    Fukumoto K, Fogaça MV, Liu RJ, Duman C, Kato T, Li XY, Duman RS.
    Proc Natl Acad Sci U S A; 2019 Jan 02; 116(1):297-302. PubMed ID: 30559184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.